Top Markets
Coin of the day
Syntara Limited Syntara Limited

Syntara Limited

SNT
Κατάταξη σε μετοχές #28269
Syntara Limited is a clinical-stage biopharmaceutical company dedicated to... Syntara Limited is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies by targeting extracellular matrix dysfunction, primarily through amine oxidase chemistry. Headquartered in Frenchs Forest, Australia, the company's research pipeline focuses on blood cancers as well as a range of inflammatory and fibrotic disorders. Its leading investigational compound, amsulostat, is currently in Phase 1c/2 clinical trials for the treatment of myelofibrosis, a bone marrow cancer, and is also being evaluated for myelodysplastic syndrome. Beyond this, Syntara is advancing several other promising drug candidates. These include a suite of topical pan-LOX inhibitors: SNT-9465, which is undergoing Phase 1a/b study for hypertrophic scars, and SNT-6302, designed for keloid scars. Furthermore, SNT-4728 is in development to manage sleep disorders and to potentially slow the progression of neurodegenerative conditions by mitigating neuroinflammation. The company's broader therapeutic ambitions extend to various fibrotic and inflammatory diseases such as kidney fibrosis, MASH (metabolic dysfunction-associated steatohepatitis), pulmonary fibrosis, and cardiac fibrosis. Incorporated in 1998, the company was formerly known as Pharmaxis Ltd before adopting the name Syntara Limited in December 2023.
Τιμή μετοχής
$0.0183374
Κεφαλαιοποίηση
$27.51M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
9.62%
Χώρα
AU
Εμπόριο Syntara Limited (SNT)

Κατηγορία

Ιστορικό τιμής μετοχής για την Syntara Limited (SNT)
Υψηλότερη τιμή κλεισίματος: $0.02 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $0.28 στις 2003-11-01
Ιστορικό τιμής μετοχής της Syntara Limited από 2003 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -1.09%
2025 -51.46%
2024 153.74%
2023 -58.49%
2022 -59.91%
2021 52.34%
2020 -53.70%
2019 -23.78%
2018 -2.79%
2017 0.17%
2016 -3.02%
2015 255.75%
2014 -40.87%
2013 -92.56%
2012 20.50%
2011 -60.61%
2010 14.15%
2009 213.96%
2008 -78.00%
2007 51.46%
2006 56.14%
2005 152.82%
2004 102.33%
2003 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$171.67 -
DE
$164.10 26.13%
DE
$37.95 22.53%
JP
$222.33 34.29%
CH
$20.95 11.61%
IN